Some of your favorite Drug and Device Law bloggers will be presenting at Reed Smith’s Philadelphia Life Sciences CLE Day on Thursday, November 10 at Reed Smith’s Philadelphia office.

Blogger Eric Alexander starts the day off with a discussion of the major drug and device decisions of 2016.  For our loyal readers who look forward to our annual “Top 10 Best and Worst Decisions,” here’s your chance for a potential sneak peek.

Then Bloggers Bexis and Rachel Weil wrap the day up with a presentation on implied preemption – as well as an update on off-label promotion since the FDA will have just held its meeting on the subject.

In between, some of our other Reed Smith colleagues will cover the post-Escobar landscape for False Claims Act claims, provide a primer on the biologics-biosimilars landscape, offer perspectives on the current best and worst product liability jurisdictions, and discuss the role of the Federal Communication Commission in regulating wireless medical devices.

We’ll even give you breakfast and lunch.

The sessions are presumptively approved for 6 CLE credits in New Jersey and 5 CLE credits in Pennsylvania. An application for Delaware credit is pending and, for lawyers licensed in New York, the day is eligible for 6 credits under New York’s Approved Jurisdiction Policy.

Interested?  You can learn more about the event here and you can register here.  Please note that the program is geared toward in-house counsel (who will be given preference), and space is limited.